((1,3-Benzothiazol-2-ylmethyl){[2-(1H-indol-5-yl)-4-methyl-1,3-thiazol-5-yl]carbonyl}amino)acetic acid

ID: ALA481405

Chembl Id: CHEMBL481405

PubChem CID: 44571296

Max Phase: Preclinical

Molecular Formula: C23H18N4O3S2

Molecular Weight: 462.56

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nc(-c2ccc3[nH]ccc3c2)sc1C(=O)N(CC(=O)O)Cc1nc2ccccc2s1

Standard InChI:  InChI=1S/C23H18N4O3S2/c1-13-21(32-22(25-13)15-6-7-16-14(10-15)8-9-24-16)23(30)27(12-20(28)29)11-19-26-17-4-2-3-5-18(17)31-19/h2-10,24H,11-12H2,1H3,(H,28,29)

Standard InChI Key:  BAAZKGXCTRVBMU-UHFFFAOYSA-N

Associated Targets(non-human)

rbsK Ribokinase (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 462.56Molecular Weight (Monoisotopic): 462.0820AlogP: 4.94#Rotatable Bonds: 6
Polar Surface Area: 99.18Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.96CX Basic pKa: 1.66CX LogP: 3.73CX LogD: 0.55
Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.37Np Likeness Score: -1.83

References

1. Desroy N, Moreau F, Briet S, Le Fralliec G, Floquet S, Durant L, Vongsouthi V, Gerusz V, Denis A, Escaich S..  (2009)  Towards Gram-negative antivirulence drugs: new inhibitors of HldE kinase.,  17  (3): [PMID:19124251] [10.1016/j.bmc.2008.12.021]

Source